Home » Newsletters » BioWorld Science

BioWorld Science

March 30, 2000

View Archived Issues

Myogen issued patent for heart failure combination

Organogenesis receives milestone payment related to Apligraf progress

Clinical trial of STR in Ewing's sarcoma initiated by NeoRx

Antagonists of alcohol's harmful effects in nerve cells discovered

Barr and DuPont mount development and marketing venture

Immunostimulatory sequence designed by Dynavax reduces HSV-2 severity

Vanguard Medical signs collaboration with WIBR for CNS disorders

Consensus receives SBIR grant to develop new class of HIV inhibitors

HPV vaccine alliance established by MediGene and Schering AG

Preliminary results from pivotal trial of Uniprost promising

ICAgen and Yamanouchi to develop novel CNS therapeutics

Agents for thrombocytopenia discovered at Kyowa Hakko

Sankyo presents newest antifungal triazoles

Potent antistaphylococcal activity exerted by Sankyo's new carbapenems

Novel antiviral agents in development at ViroPharma for Flaviviridae infections

Pfizer claims NSAIDs linked to NO-releasing moiety associated with reduced GI toxicity

Repligen initiates largest-ever study in autism

Novel peptides and their use in the treatment of diabetes reported by Amylin

Study indicates functional abnormalities in children with ADHD

ACS news: subtype-selective NMDA receptor antagonists with potential in PD

Benzimidazole inhibitors of V-ATPase designed at Fujisawa for osteoporosis Rx

SAR for beta-turn mimetics of enkephalin discussed at ACS by Molecumetics

Inhibitors of cdk2 pursued by CV Therapeutics for use in restenosis

HMR-1556 selected for further evaluation as antiarrhythmic agent, presented to ACS

AltaRex presents clinical plan for OvaRex at BIO 2000 annual meeting

KT3-671 beneficial in diabetic nephropathy according to recent preclinical results

SmithKline Beecham claims 5-HT6 antagonists for ADHD

Hemodynamic effects of AH-1058 evaluated by telemetry in dogs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Deals and an M&A strengthen end-of-year numbers
BioWorld
Two large deals and an acquisition, totaling about $4.64 billion in all, are helping wrap up what’s turning out to be a strong year. Through the first 11 months...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
Radiopharm Theranostics’ RAD-101 meets brain metastases endpoints
BioWorld
Radiopharm Theranostics Ltd.’s radiotracer RAD-101 met the primary endpoint in 92% of patients in the phase IIb imaging trial in brain metastases, according to...